Medical Nutrition USA Inc.

Chairman and Chief Executive Officer since 2003 and a director since November 2002. From 1993-2000 he was Chairman, President and CEO of Eckerd Corporation, one of the largest drug store chains in the United States, and from 1986-1993 was President and CEO of F&M Distributors, Inc. a drug store chain. Mr. Newman is a director of Jabil Circuit, Inc., Jo-Ann Stores and MTS Medical Technology. He has served on the board of the National Association of Chain Drug Stores since 1993, including as its Chairman (1999-2000) and is a member of the board of advisors of University of Michigan School of Pharmacy and a Trustee of Sidwell Friends School, Washington D.C.

President since the company’s formation in 1981 until 2007. Mr. Gans was previously President of Control Drug, Inc. a manufacturer of nutritional protein supplements. Mr. Gans was granted patents in 1977, which he has assigned to the Company, for method-use manufacturing for certain nutritional formula processes relating to the use of certain foods to treat nutritional deficiency. Mr. Gans has served on the Board of Holy Name Hospital in Teaneck, New Jersey. He serves on the Alumni Board of Columbia University's School of Public Health and is Chairman of the Alumni Federation Scholarship Aid Committee. Mr. Gans holds a Bachelor of Science degree in Pharmaceutical Chemistry from Columbia University.

Promoted to Senior Vice President of Operations in October 2006. Mr. Janco previously served as the Company’s Vice President of Operations since 1992. Upon joining the Company, he performed in the capacity of Operations Manager. His responsibilities include office administration, supply chain management, inside sales/customer service, human resources, information technology and logistics. He earned his Bachelor of Business Administration degree from the University of Miami.

Executive Vice President since 1982, Secretary from 1990 to December 2006. Ms. Gans has over 25 years of experience working with clinicians and hospitals to integrate the Company’s products and programs as well as in organizing seminars for physicians. Currently, Ms. Gans initiates and manages customer agreements and distribution contracts for branded products as well as all the federal, state and county bids. She is responsible for the marketing effort for branded products and handles all advertising and associated matters. Ms. Gans also develops the marketing and business plans for all new products. She attended Cornell University and Finch College and holds a Bachelor of Arts degree in English Literature.

Andrew Horowitz, J.D. has been a Director since September, 2002. His most recent ventures were Partners Healthcare, a leading institutional pharmacy company that he started in 1998, and Care Alternatives, a hospice service provider, that he acquired in 2000. Upon graduation from Emory Law School, Mr. Horowitz joined the New Jersey law firm of Norris, McLaughlin & Marcus in the practice of business and tax law. Mr. Horowitz has been in healthcare since succeeding his father in the management of Scotchwood Pharmacy, a successful pharmacy business his dad started 35 years earlier. In 1995, Scotchwood was acquired by The Multicare Companies, a nursing home company traded on the NYSE. Pursuant to that acquisition, Mr. Horowitz became Director of Multicare’s pharmacy operations and in 1996 became a senior officer in the Company, responsible for all ancillary businesses, including homecare, portable diagnostics and medical supply. Upon Multicare’s acquisition by Genesis Health Ventures in 1997, he left to develop Partners. In 2003, Partners, Care Alternatives and Solutions Healthcare, a JCAHO accredited infusion-therapy business also owned by Mr. Horowitz, were sold to investors as part of a like-kind roll-up, and he left the Company in May, 2005.

Bernard J. Korman has been a director since September 2004. Mr. Korman is Chairman of Philadelphia Health Care Trust, a Foundation dedicated to supporting healthcare delivery, research and education. After practicing law in Philadelphia for 13 years, in 1968 he founded and was Chairman, President and CEO of American Medicorp, Inc. (NYSE), one of the first public hospital management companies in the United States. From 1977 until 1995, he served as President and CEO of MEDIQ Incorporated (AMEX), a healthcare services company, and Chairman of PCI Services, Inc. (NASDAQ), a pharmaceutical packaging services company (1983-1996). Mr. Korman presently serves as a Director of The New America High Income Fund, Inc. (NYSE); Omega Healthcare Investors, Inc. (NYSE); and NutraMax Products, Inc.

Mark H. Rosenberg has been a director since March 2004. He is one of eight investment professionals at MHR Fund Management LLC, a $2 billion fund focused on middle market distressed businesses. He previously was Vice President with CRT Capital Group LLC in Greenwich, CT, where he was a Research Analyst of distressed high yield and convertible debt covering the healthcare industry, among others. He was the former president of Rosemark Management, Inc. in New York City where he managed a portfolio of operating businesses and real estate investments. He serves on the Board of Ben Arnold Sunbelt Beverage Company of South Carolina, L.P., Columbia, SC. Mr. Rosenberg graduated from the Wharton School, University of Pennsylvania and holds a Bachelors of Science in Economics, 1984.